Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials

por Uusitalo, Hannu, Egorov, Evgeniy, Kaarniranta, Kai, Astakhov, Yuri, Ropo, Auli
Publicado 2016

Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational stud...

por Pillunat, Lutz E, Erb, Carl, Ropo, Auli, Kimmich, Friedemann, Pfeiffer, Norbert
Publicado 2017

Fixed-Dose Combination of Tafluprost and Timolol in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: Comparison with Other Fixed-Combination Products

por Holló, Gábor, Vuorinen, Jouni, Tuominen, Juhani, Huttunen, Teppo, Ropo, Auli, Pfeiffer, Norbert
Publicado 2014

Changes in ocular signs and symptoms in patients switching from bimatoprost–timolol to tafluprost–timolol eye drops: an open-label phase IV study

por Bourne, Rupert Richard Alexander, Kaarniranta, Kai, Lorenz, Katrin, Traverso, Carlo Enrico, Vuorinen, Jouni, Ropo, Auli
Publicado 2019

A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preserv...

por Pfeiffer, Norbert, Traverso, Carlo E., Lorenz, Katrin, Saarela, Ville, Liinamaa, Johanna, Uusitalo, Hannu, Astakhov, Yury, Boiko, Ernest, Ropo, Auli
Publicado 2014

Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study

por Panarelli, Joseph F., Bowden, Eileen C., Tepedino, Michael E., Odani-Kawabata, Noriko, Pei, Zifan, McLaurin, Eugene B., Ropo, Auli
Publicado 2023